Impacto clínico del desescalamiento a ertapenem en pacientes críticos con infecciones por Enterobacteriaceae

Diana P. Cuesta, Victor M. Blanco, Marta E. Vallejo, Cristhian Hernández-Gómez, Juan J. Maya, Gabriel Motoa, Adriana Correa, Lorena Matta, Fernando Rosso, Ruben D. Camargo, Martin Muñoz, Elizabeth Florez, Jorge Nagles, Amparo Ovalle, Sergio Reyes, María V. Villegas

    Producción científica: Contribución a una revistaArtículo en revista científica indexadarevisión exhaustiva

    2 Citas (Scopus)

    Resumen

    Background: Ertapenem has proven to be effective for extended-spectrum beta-lactamases-producing Enterobacteriaceae but lacks activity against non-fermenters; de-escalation to this antibiotic may reduce the selection of resistance to Pseudomonas aeruginosa and improve clinical outcomes. Aim: To evaluate the clinical impact of de-escalation from broad-spectrum anti-pseudomonal agents to ertapenem, a non-pseudomonal antibiotics for Enterobacteriaceae infections in critically-ill patients. Methods: We conducted a prospective cohort study in adult patients admitted to intensive care units (ICUs) who had Enterobacteriaceae infections and were deescalated from empiric anti-pseudomonal coverage to non-pseudomonal antibiotics. Cox proportional hazards models were performed comparing all-cause mortality and length of hospital stay between patients who remained on anti-pseudomonal coverage versus those who were de-escalated to ertapenem. Results: 105 patients in the anti-pseudomonal group were compared to 148 patients in the ertapenem de-escalation group. De-escalation was associated with lower all-cause mortality compared to patients who remained on anti-pseudomonal coverage (adjusted Hazard Ratio 0.24; 95% CI: 0.12-0.46). The length of ICU stay was similar between the groups. Discussion: ICU patients with Enterobacteriaceae infections de-escalated to ertapenem therapy had better outcomes compared to patients who remained on broad-spectrum, anti-pseudomonal therapy, suggesting that de-escalation is a safe approach amongst ICU patients.

    Título traducido de la contribuciónClinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections
    Idioma originalEspañol
    Páginas (desde-hasta)9-15
    Número de páginas7
    PublicaciónRevista Chilena de Infectologia
    Volumen36
    N.º1
    DOI
    EstadoPublicada - feb. 2019

    Nota bibliográfica

    Publisher Copyright:
    © 2019, Sociedad Chilena de Infectologia. All rights reserved.

    Palabras clave

    • De-escalation
    • Enterobacteriaceae Infections
    • Ertapenem
    • Intensive care unit
    • Mortality

    Tipos de Productos Minciencias

    • Artículos de investigación con calidad Q4

    Huella

    Profundice en los temas de investigación de 'Impacto clínico del desescalamiento a ertapenem en pacientes críticos con infecciones por Enterobacteriaceae'. En conjunto forman una huella única.

    Citar esto